Michael A. Briggs

744 total citations
11 papers, 203 citations indexed

About

Michael A. Briggs is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Biotechnology. According to data from OpenAlex, Michael A. Briggs has authored 11 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Biotechnology. Recurrent topics in Michael A. Briggs's work include Melanoma and MAPK Pathways (3 papers), Cancer Mechanisms and Therapy (2 papers) and Cancer Research and Treatments (2 papers). Michael A. Briggs is often cited by papers focused on Melanoma and MAPK Pathways (3 papers), Cancer Mechanisms and Therapy (2 papers) and Cancer Research and Treatments (2 papers). Michael A. Briggs collaborates with scholars based in United Kingdom, United States and Canada. Michael A. Briggs's co-authors include G. Daniel Lassiter, Robert E. Bowman, Andrew Billinton, Iain P. Chessell, Nick M. Clayton, Carl Haslam, William L. Mitchell, Brian P. Slingsby, Alex Wilson and Andrew J. Brown and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Michael A. Briggs

10 papers receiving 174 citations

Peers

Michael A. Briggs
Jieon Lee South Korea
Garima Gupta India
David L. Norton United Kingdom
Lawrence B. Katz United States
Arthur Gutman United States
Sarah H. Awad Denmark
J. Allan Campbell United States
Allison F. Wagner United States
Jieon Lee South Korea
Michael A. Briggs
Citations per year, relative to Michael A. Briggs Michael A. Briggs (= 1×) peers Jieon Lee

Countries citing papers authored by Michael A. Briggs

Since Specialization
Citations

This map shows the geographic impact of Michael A. Briggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Briggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Briggs more than expected).

Fields of papers citing papers by Michael A. Briggs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Briggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Briggs. The network helps show where Michael A. Briggs may publish in the future.

Co-authorship network of co-authors of Michael A. Briggs

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Briggs. A scholar is included among the top collaborators of Michael A. Briggs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Briggs. Michael A. Briggs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ciccone, David, Ian D. Linney, Michael A. Briggs, et al.. (2021). Abstract 1649: Mechanistic understanding of HPK1 inhibition on enhanced human T cell activation and tumor immunity in a syngeneic model. Cancer Research. 81(13_Supplement). 1649–1649. 1 indexed citations
2.
Ciccone, David, Ian D. Linney, Michael A. Briggs, et al.. (2020). 685 A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model. SHILAP Revista de lepidopterología. A411.1–A411. 1 indexed citations
3.
Ciccone, David, Ian D. Linney, Michael A. Briggs, et al.. (2020). A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model. European Journal of Cancer. 138. S20–S20. 1 indexed citations
4.
Ciccone, David, Jennifer L. Rocnik, Ian D. Linney, et al.. (2020). Abstract 942: HPK1, hematopoietic progenitor kinase 1, is a promising therapeutic target for cancer immunotherapy. Cancer Research. 80(16_Supplement). 942–942.
5.
Briggs, Michael A., et al.. (2015). Behaviour of fibre-reinforced concrete beams on grade. International Journal of Physical Modelling in Geotechnics. 16(4). 152–159. 1 indexed citations
6.
Giblin, Gerard M.P., Andrew Billinton, Michael A. Briggs, et al.. (2009). Discovery of 1-[4-(3-Chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a Brain Penetrant 5-Azaindole CB2Agonist for the Treatment of Chronic Pain. Journal of Medicinal Chemistry. 52(19). 5785–5788. 43 indexed citations
7.
Witherington, Jason, Michael A. Briggs, David K. Dean, et al.. (2008). Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: Lead optimisation. Bioorganic & Medicinal Chemistry Letters. 18(6). 2203–2205. 12 indexed citations
8.
Briggs, Michael A., Tsu Tshen Chuang, Nigel Deeks, et al.. (2008). Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(20). 5698–5700. 15 indexed citations
9.
Lassiter, G. Daniel, et al.. (1992). The Potential for Bias in Videotaped Confessions1. Journal of Applied Social Psychology. 22(23). 1838–1851. 43 indexed citations
10.
Lassiter, G. Daniel, Michael A. Briggs, & Robert E. Bowman. (1991). Need for Cognition and the Perception of Ongoing Behavior. Personality and Social Psychology Bulletin. 17(2). 156–160. 41 indexed citations
11.
Lassiter, G. Daniel, et al.. (1991). Need for Cognition, Causal Processing, and Memory for Behavior. Personality and Social Psychology Bulletin. 17(6). 694–700. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jieon Lee Breakdown of academic impact, for papers by Garima Gupta Breakdown of academic impact, for papers by David L. Norton Breakdown of academic impact, for papers by Lawrence B. Katz Breakdown of academic impact, for papers by Arthur Gutman Breakdown of academic impact, for papers by Sarah H. Awad Breakdown of academic impact, for papers by J. Allan Campbell Breakdown of academic impact, for papers by Allison F. Wagner
Rankless by CCL
2026